SYNBIOTIC Secures International Investors for Expansion

SYNBIOTIC SE, a European holding company in the medical cannabis and industrial hemp sectors, is enhancing its access to international capital. Partnering with North American specialists, SYNBIOTIC aims to attract long-term global investors to support its buy-and-build strategy. This move is expected to accelerate its growth compared to competitors.

CEO Daniel Kruse emphasized the company's readiness to lead the next industry phase, highlighting collaboration with firms like Hyde Advisory, Bob Hoban, and Golden Eagle Partners to expand its network. These partnerships provide strategic guidance in investor relations, cross-border strategies, and regulatory compliance.

Through these alliances, SYNBIOTIC improves its visibility among potential investors, strengthening its market presence. This initiative underscores the company's commitment to expanding its business in Europe and beyond, building on positive industry momentum.